Medtechs dominated the ASX boards this week with one company rocketing nearly 1500 per cent after getting approval to enter the US market, its rise was so strong it dragged a partner up as well. FLASHPOINT - TRANSCRIPT Tim - But first here's Matt Birney with the ASX Runners of the Week. Tim - Thanks to Argonaut Matt Birney - Thanks Tim. Matt Birney - Well, MedTech company Lumos Diagnostics bolted 1,491 per cent this week after the US FDA gave its respiratory infection test th